11.3 months, HR 0.77, 95% CI 0.59–1.00), but it did not reach statistical significance ( p = .026 vs. the prespecified threshold of p = .0246), making the positioning of everolimus in slowly growing functioning NETs somewhat weaker.
← all excerpts
European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids.
1
0.0260
0.0260